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Abstract
Shrestha, Utsav M.S. The University of Memphis. August 2020. Quantitative Analysis and
Monte Carlo Modeling of Fat-Mediated MRI Relaxation. Major Professor: Dr. Nirman Kumar.
Hepatic steatosis is the accumulation of fat in the liver, affecting about 25% of the world
population. Steatosis can cause lipo-toxicity and eventually lead to fibrosis, cirrhosis and
ultimately liver failure if timely interventions are not provided. So, early diagnosis and disease
monitoring of steatosis is crucial to reduce morbidity and mortality. Chemical shift based
Magnetic Resonance Imaging (MRI) techniques using single and dual 𝑅2∗ (transverse relaxation
rate) models have been reported to quantify fat fraction (FF) for assessment of steatosis.
However, there is no common consensus between these two models and current data is limited
for which model is accurate to quantify FF. Fully characterizing the behavior of the models over
the entire clinical range of hepatic steatosis is essential to determine the limits of each of the
models. However, performing a systematic investigation of the 𝑅2∗ models in patient population
is infeasible. This thesis presents a computational approach by building a Monte Carlo based
model as an alternative way to examine the 𝑅2∗ -MRI models.
A 3D liver volume with impenetrable fat spheres was simulated to mimic hepatic steatosis.
The simulation of steatosis was done using realistic data obtained from automatic segmentation
and characterization of fat droplets using liver biopsy images. MRI signals were synthesized in
the virtual liver volume using Monte Carlo modeling approach. Finally, the 𝑅2∗ behavior was
analyzed using both the single and dual 𝑅2∗ models and they were compared against in-vivo
calibration to determine their accuracy. Predicted 𝑅2∗ values were within confidence bounds of
the published in vivo calibration and single 𝑅2∗ model showed higher accuracy than dual 𝑅2∗
model to estimate FF.
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In conclusion, this research developed a computational framework for creating realistic
hepatic steatosis model and synthesizing MRI signal and analyzing 𝑅2∗ behavior in the presence
of fat. The developed computational methods will also be generalizable to create other tissuespecific models and study 𝑅2∗ behavior at higher field strengths, for testing new MRI pulse
sequences and in presence of other co-existing pathologies such as hepatic iron overload.
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Chapter 1 Introduction
Overview
Hepatic steatosis is the accumulation of fat in the liver, affecting about 25% of the world
population 1. Steatosis can cause lipo-toxicity and eventually lead to fibrosis, cirrhosis and
ultimately liver failure. As steatosis is reversible condition, early diagnosis and disease
monitoring is crucial to reduce morbidity and mortality. Liver biopsy is the current gold standard
for the assessment of steatosis. However, biopsy is invasive, painful and suffers from sampling
error 2. In recent years, Magnetic Resonance Imaging (MRI) has evolved as a noninvasive
alternative to biopsy for diagnosis of hepatic steatosis 3-5. Chemical shift-based MRI techniques
that incorporate MRI transverse relaxivity (𝑅2∗ ) have been reported to quantify Fat Fraction (FF)
for assessment of steatosis. 6-8. There are two 𝑅2∗ models based on this technique: single 𝑅2∗
model which considers common 𝑅2∗ for fat and water and dual 𝑅2∗ model which uses different 𝑅2∗
for fat and water. There is no common consensus between these two models and current data is
limited for which model is accurate to quantify FF. It may not be feasible and can be expensive
as well as time-consuming to analyze these models over entire clinical range of FF using patient
cohort.
This thesis investigates a computational approach as an alternative way to simulate hepatic
steatosis, synthesize MRI signal and analyze MRI relaxivities for determining an accurate model
for the quantification of steatosis. An outline of this study is shown in Figure 1. The main
components of this research are:
1. To design an algorithm for automatic segmentation of Fat Droplets (FDs) and quantification
of FF from liver histology images.
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2. To statistically model distributions for the properties of FDs (radius, nearest neighbor (NN)
distance and regional anisotropy) from the segmented images for building a virtual steatosis
model.
3. Finally, to synthesize MRI signal in the simulated hepatic steatosis volume using Monte
Carlo modeling and analyze the 𝑅2∗ behavior using both 𝑅2∗ models to determine their
accuracy.

Figure 1-1. An overview of the project
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Monte Carlo modeling
Monte Carlo modeling is a computerized mathematical method that applies repeated random
sampling rather than using single average value to produce an outcome. It works by constructing
a mathematical model of the problem under consideration then runs the simulation for any
uncertain aspects of the model. The simulation of MRI signal depends upon water proton’s
mobility in liver, magnetic field inhomogeneities and the effects of radiofrequency pulses. These
form the building blocks of Monte Carlo simulation. Particle size and distribution of FDs
extracted from liver biopsy images can be incorporated into the Monte Carlo model to produce
realistic magnetic field inhomogeneities. To simulate the diffusion of water protons, the model
can use statistical descriptions of proton movement (such as diffusion tensor) or simply assume
isotropic diffusion in 3D. The phase accumulated by different proton paths while moving freely
in the tissue environment can be used to mimic the MRI signal. Hence, Monte Carlo modeling
breaks down complicated physical systems into many smaller sub problems and has been
beneficial in simulating and studying various MRI experiments 9-12.
Specific aim and Significance
The primary aim of this project is to understand the underlying mechanisms of fat-water
proton interactions in hepatic steatosis by using Monte Carlo modeling. For this, we aim to
create a computer program for automatic segmentation and characterization of FDs from liver
histology images and build a steatosis model using the characteristics of FDs. The secondary aim
of this research is to simulate MRI signal using Monte Carlo modeling and test the robustness of
this model by comparing the model predicted relaxivities with the in-vivo calibration.
The success of this project will help build realistic tissue specific steatosis model. Moreover,
it will aid to understand the fat-mediated relaxivity in tissues and determine an accurate model to
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quantify FF for non-invasive assessment of steatosis. The developed computational methods will
also be generalizable to create other tissue-specific models and study 𝑅2∗ behavior at higher field
strengths, for testing new MRI pulse sequences and in presence of other co-existing pathologies
such as hepatic iron overload.
Working Hypothesis
Given the size and distribution of FDs, Monte Carlo modeling will be able to simulate MRI
signal in presence of fat and 𝑅2∗ behavior can be investigated using multi-spectral fat-water 𝑅2∗
signal models.
Outline
Chapter 2 discusses about fat metabolism in human body, how excess fat gets stored in liver
leading to hepatic steatosis and then explains the causes, effects, diagnosis and treatment of
hepatic steatosis. In addition, it introduces MRI principles and describes about how the presence
of fat affects the MRI signal and the limitations of current signal models.
Chapter 3 describes the image acquisition from liver histology slides and the development
and implementation of an algorithm for automatic segmentation and characterization of FDs.
Chapter 4 derives statistical models for describing the size and distribution of FDs with
respect to FFs and builds a virtual hepatic steatosis model.
Chapter 5 describes the generation of MRI signal from the virtual steatosis model using
Monte Carlo modeling, analyzes the 𝑅2∗ models and compares the predicted 𝑅2∗ behavior to in
vivo 𝑅2∗ -FF calibration.
Chapter 6 concludes the thesis by discussing the contributions and findings of this project
and presents some future prospects.
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Chapter 2 Hepatic Steatosis and MRI
Fat Homeostasis
This section discusses about the fat cycle in human body and is intended to discuss how
excess fat gets accumulated in liver. Fat is a major source of energy in the human body.
Triglyceride is the main type of fat acquired from food sources and fat can store more than
double the energy content of carbohydrates or proteins 13. Triglycerides are also synthesized by
adipocytes or hepatocytes. Fat in the form of phospholipids, triglycerides and cholesterol is a
major constituent of cell membrane. Omega-(n)3 and docosahexaenoic acid (DHA) are major
forms of fatty acid found in the membrane of brain and retina 14. Also, fat is a transporter of fatsoluble vitamins A, D, E and K to the intestine where they are absorbed. Fat deposits help to
insulate the human body and shield vital organs.
According to U.S. Department of Agriculture 2015-2020 dietary guidelines, daily diet for an
adult can contain up to 35% of total calories from fat per day which is about 77 grams of fat per
day. Blood glucose level rises after eating which triggers pancreas to produce insulin. Insulin is
the hormone that regulates the operation of liver. After the production of insulin, body starts to
absorb glucose from the blood. In response to increase in insulin, the liver starts absorbing
glucose and packages them into bundles to form glycogen. As the glucose level drops, pancreas
stops producing insulin. This signals the liver to decompose its stored glucose and send it back to
the blood. This helps the body to maintain energy between meals and overnight.
If the liver is full of glycogen, the absorbed glucose is converted to fatty acids by the liver
which acts as a long-term storage of energy. The fatty acids are transported around the body via
blood which are absorbed by fat tissues. Sometimes, the liver ends up accumulating fat while
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producing and storing the extra fat instead of sending it to fat cells. This condition is known as
Non-Alcoholic Fatty Liver Disease (NAFLD).
When excess fats are produced or ingested and stored in fat cells then people become obese.
According to study, 51% of the population will suffer from obesity by 2030 15. Obesity can
trigger bone-thinning osteoporosis and heart disease risk. Moreover, it can lead to insulin
resistance and type 2 diabetes 16.
Hepatic Steatosis
This section discusses about the causes, effects as well as diagnosis and treatment techniques
of hepatic steatosis. Its main purpose is to understand the severity of the disease and why a
proper diagnosing method is required for the disease.
Causes and Prevalence
Hepatic Steatosis is the accumulation of fat in liver where at least 5% of the hepatocytes
contain fat vacuoles. It is mainly associated with insulin resistance, obesity and high levels of fat
(triglycerides) and sugar in blood. In addition, fatty liver is also seen in Drug-Induced Liver
Injury (DILI) 17 and is also confirmed as a side-effect of cancer chemotherapy 18,19. Based on the
cause, it can be divided into: Alcoholic Fatty Liver Disease (AFLD) and NAFLD.
Approximately 25% of the world population is being affected by NAFLD (1 .
Types of Steatosis
Morphologically, steatosis can be categorized into two major groups:
1. Macrovesicular steatosis
Macrovesicular steatosis (a.k.a. macrosteatosis) is when Fat Droplets (FDs) are large enough
to be able to displace the nucleus and organelles of hepatocytes to the cell periphery. There is
6

only one FD per hepatocyte. It primarily occurs in NAFLD. In addition, macrovesicular steatosis
is a primary source of MRI signal in patients with steatosis 20.
2. Microvesicular steatosis
Microvesicular steatosis (a.k.a. microsteatosis) occurs when FDs are tiny, and they
accumulate to provide a foamy appearance to the cytoplasm without shifting the nucleus. It is
mainly associated with AFLD 21. In later stage, the tiny FDs of microsteatosis combine with each
other to form larger FDs resulting in macrosteatosis.
Effects
Hepatic Steatosis, if not treated on time, can cause liver scarring which is known as liver
fibrosis. With time, liver fibrosis will develop into cirrhosis which is life threatening and
irreversible. Cirrhosis related to NAFLD is predicted to be the top sign for liver transplantation
in the USA in next two decades 22. If NAFLD is accompanied by liver inflammation, then it is
known as nonalcoholic steatohepatitis (NASH), which can lead to cirrhosis and liver failure.
About 50% of patients have NASH and 19% have cirrhosis along with NAFLD at the time of
diagnosis 23.
Treatment
Although hepatic steatosis is the most common liver disease in the US, no FDA guidelines or
approved pharmacologic agents are available yet. There is active research going on in this field
and some of them are:
1. Weight loss: It is a natural way to counter hepatic steatosis. It helps to lower insulin level in
blood 24. Several studies have been conducted reporting decrease in hepatic steatosis by
weight loss 24-26.
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2. Bariatric surgery: Bariatric surgery 27 has proved to be successful in the treatment of hepatic
steatosis by multiple research studies 28-30 but its durability is yet to be determined.
3. Orlistat: It is a technique for weight loss by reducing fat absorption. Successful reversal of
fatty liver using orlistat has been documented in multiple studies 31,32. The major side effects
of this procedure are gas and bloating.
4. Sibutramine: Like orlistat, it helps in weight loss by decreasing appetite. Experiments have
been conducted using this method and decreased evidence of hepatic steatosis has been found
31

. It has similar side effect to orlistat.

5. Pharmacological therapy: There are several pharmacological therapies available to cure
hepatic steatosis. Some of them are: Thiazolidinediones, rosiglitazone, Metformin, Statins,
fibric acid derivatives (such as Gemfibrozil), etc. Currently, statins are used for the treatment
of NAFLD 23.
Diagnosis
The major methods to diagnose hepatic steatosis are:
1. Liver Biopsy: It is the process of extracting sample of liver tissue by inserting a needle into
the liver. It is the current gold standard to access hepatic steatosis. In liver biopsy, FDs have a
distinct characteristic of white round structure. However, it is invasive and suffers from
sampling error as well as interobserver variability.
2. Ultrasound: Liver ultrasound is a non-invasive technique to detect hepatic steatosis. It is
currently the most accessible and inexpensive method for the purpose. In the presence of
hepatic steatosis, liver appears brighter than the surrounding organs (renal cortex and spleen).
It also causes attenuation of ultrasound waves 33. However, the accuracy of ultrasound
depends upon operation parameters and is less sensitive if steatosis is less than 30% 34. In
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addition, the quantification of steatosis can be affected by the heterogeneity in NAFLD
patients.
3. Computerized Tomography (CT): Among the CT techniques, contrast unenhanced CT is the
most accurate to detect and quantify hepatic steatosis 35. For identifying steatosis, the
difference in attenuation of liver and spleen play an important role. In normal liver, the
average attenuation value for liver is at least 4 Hounsfield Unit (HU) higher than that for
spleen 36. In contrast, the attenuation value for fatty liver is at least 10 HU lower than that of
the spleen 34. This results in darker appearance of liver rather than brighter. However, CT
scans are not sensitive to detect hepatic steatosis less than 30% 37. Also, studies have shown
that unenhanced CT for quantification of macrosteatosis is not clinically acceptable 38.
Moreover, CT uses ionizing radiation to image internal organs which is harmful and is less
suitable for follow-up of patients.
4. Magnetic Resonance Imaging (MRI): MRI is non-invasive as well as it does not use any
radiation for imaging. MRI can detect hepatic steatosis and is reported to be the most
sensitive technique 37,39,40. MRI can quantify steatosis in terms of Fat Fraction (FF) by
acquiring images throughout the liver volume. High accuracy of MRI-FF has been
documented by several studies 39,41,42.
MRI for diagnosis of hepatic steatosis
As we aim to simulate MRI signal, this topic provides an insight of what happens when a
patient undergoes MRI scanning which helps to figure out minute details (such as magnetic fieldspin excess relationship, phase of protons and relaxivity) required for the simulation.
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MRI mechanism
Human body comprises of about 70% water by weight. The hydrogen nucleus in water is
composed of a single proton which makes it suitable for MRI imaging. The hydrogen has one
proton and one electron and both spin around their own axis (Figure 1). Since proton is
positively charged and electron is negatively charged, they form a tiny current loop when they
spin. This current loop produces magnetic field. However, proton is much larger than electron so
the magnetic dipole produced by the proton will dominate over electron.

Figure 2-1. Proton and electron spin in Hydrogen atom.
Although the hydrogen atoms possess the property of magnetic dipole, there is no net
magnetization in our body because the hydrogen protons are randomly oriented. When an
external magnetic field (B0) is applied to the human body, some of the magnetic dipoles of
hydrogen protons align in the direction of B0 while others align anti-parallel to B0. At any
temperature above absolute zero, at least few of the protons align more in one direction than the
other. So, there exists a net magnetization from the protons. The difference in the number of
protons in either of the direction is known as ‘spin excess’. Although spin excess is small, there
are a huge number (Avogadro number) of molecules in each mole of water (i.e. 6.023 x 1023
molecules/mole) and the resulting MRI signal is measurable. After the alignment of protons due
to B0, the spinning protons precess about the axis of B0 (Figure 2) with frequency ω0 given by,
𝜔0 = 𝛾 ∗ 𝐵0
where, 𝛾 is the gyromagnetic ratio which is approximately 42.58 MHz/T for protons.
10

Figure 2-2. Proton spins in the (a) absence and (b) presence of external magnetic field B0

Figure 2-3. Magnetic moment vector of proton
Let M0 be the magnetization of excess spins that is aligned parallel towards B0. The
components of M0 (blue arrow) are MZ (red arrow) and MXY (green arrow) in Z-axis and XYplanes respectively (Figure 3). Even if the number of excess spins is large, the magnitude of M0
will still be small in comparison to B0. Hence, to detect signal from the protons, M0 should be
tipped onto XY plane (i.e. perpendicular to B0) which is done by applying a Radio Frequency
(RF) pulse whose frequency is same as 𝜔0 and is oriented in the transverse plane. When the RF
pulse is turned off, the M0 vector starts uncoiling back to its equilibrium position. The phase
coherence between all the spinning protons starts to get out of phase.
11

The increase in magnetization in longitudinal direction is caused by the release of absorbed
energy from the protons back to the surrounding environment (lattice). This process is known as
spin-lattice relaxation and the time taken to restore MZ is called T1 relaxation, which is
represented by,
𝑡

𝑀𝑍 (𝑡) = 𝑀0 (1 − 𝑒 −𝑇1 )
As the magnetization starts to be restored in the Z direction, signal decay occurs in transverse
plane due to the dephasing of proton spins with respect to each other. This phenomenon is
known as T2 relaxation. Generally, T2 is less than T1 of the order of 5-10 times. The T2
relaxation is given by,
𝑡

𝑀𝑋𝑌 (𝑡) = 𝑀𝑋𝑌 (0) ∗ 𝑒 −𝑡2
where, 𝑀𝑋𝑌 (0) is the initial transverse component of M0 when it is tipped onto the XY-plane.
T2 relaxation is intrinsic and irreversible which occurs by natural interaction among spins.
However, the B0 is not uniform which causes magnetic field inhomogeneity and the T2 value
decreases further. In this case, T2 is known as T2* which represents the effective transverse
relaxation. The T1, T2 and T2* are constant for specific tissue and they are known as relaxation
times. The inverse of relaxation times are known as relaxivities (aka, relaxation rates) denoted by
R1, R2 and 𝑅2∗ respectively.
Fat induced effects in MRI
Hydrogen protons resonate at a constant but unique frequency depending on the molecular
structure of compounds. This phenomenon is known as chemical shift which is caused because
hydrogen protons experience different magnetic field strength depending upon the chemical
environment. The hydrogen protons are provided with intrinsic shielding from surrounding
electrons that alters the strength of external magnetic field acting on it. For example, the
12

hydrogen proton in water (O-H bond) will experience slightly stronger magnetic field as
compared to the hydrogen proton in fat (C-H bond) because hydrogen will have less nearby
electrons in O-H bond. So, the hydrogen proton in water resonate at a slightly higher frequency.
These differences are small and measured in parts per million (ppm) 43. Due to the difference in
resonance frequency, the signals of water and fat will become in-phase and out-of-phase at
different time points and introduce oscillations in the MRI signal. Hence, in patients with hepatic
steatosis, there arises intensity difference between in-phase and out-of-phase images whereas the
intensity of these two images for a normal liver will be same. This principle has been used to
detect hepatic steatosis by Dixon 44. Multiple studies have been conducted using this method
describing it as a clinically useful technique to identify and quantify steatosis 45,46. However, this
method is time-consuming, and the images are affected by motion artifacts and magnetic field
inhomogeneities and more importantly, Dixon methods do not consider T2* decay and can
corrupt fat estimates 47. This is because for fat quantification, signal is collected over multiple
echo times during which T2* decay occurs. Recent studies corrected for the confounding effect
of T2* decay by incorporating 𝑅2∗ (1000/T2*) into the signal model and simultaneously
estimated 𝑅2∗ and Fat Fraction (FF) 3,4,48.
Existing issues with signal models
Most of the studies that use 𝑅2∗ correction assume the 𝑅2∗ decay rate of fat and water to be
same (single 𝑅2∗ ) for simplicity. This technique has been reported to be successful for accurate
FF quantification 6,49. However, if the 𝑅2∗ decay rate of fat and water are not similar then single
𝑅2∗ model may not be accurate. So, dual 𝑅2∗ model which considers independent 𝑅2∗ decay rates
for fat and water has been proposed and it has been shown that this method improves the
accuracy of FF estimation using phantom experiments 50. However, dual 𝑅2∗ is mathematically
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complicated and does not perform well with noise which hampers the FF quantification accuracy
. Single 𝑅2∗ has been demonstrated to be more accurate than dual 𝑅2∗ using simulation and

51

phantom studies 51 and patient cohort 52. There is no common consensus between these two
models and current data is limited for which model is accurate to simultaneously quantify FF and
𝑅2∗ .
Hence, there is a need to compare the impact of single 𝑅2∗ and dual 𝑅2∗ correction for
estimation of FF. To evaluate the models over entire clinical range of hepatic steatosis, a
systematic investigation over a patient population would be necessary but this is not practically
feasible. Alternatively, a model-based approach such as Monte Carlo modeling where the
simulation of steatosis is done using realistic data from liver biopsy can be useful to reduce or
eliminate the need of patient cohorts.
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Chapter 3 Automatic Segmentation of Fat Droplets in Hepatic Steatosis using Histology
Introduction
Liver biopsy, the current gold standard to diagnose hepatic steatosis, when imaged under
microscope shows FDs as white circular blobs. Analyzing the FF in a biopsy image by a
pathologist is time consuming and subjective. So, an accurate and automatic fat quantification
method would help to detect NAFLD at an early stage.
Multiple techniques have been used to automate the analysis of quantifying steatosis using
liver histological slides 53-57 Some studies used commercial software that quantified steatosis by
morphometric analysis. 53,54 More recent studies trained a supervised machine learning model
based on annotated images provided by pathologists to identify macrosteatosis regions and
calculate its percentage. 55,56 Unsupervised clustering such as k-means has also been implemented
for segmentation of FDs. 57 Other approaches used morphological process such as erosion and
dilation along with shape features like eccentricity and roundness 58-60. This study uses
thresholding, morphological operation and shape measurements along with a new approach of
analyzing the change in area brought by morphological operators to successfully segment the
FDs and compute its FF.
Materials and Methods
Sixteen liver biopsy specimens from mice fed for 7 weeks with rich high fat diets were
collected. Mice age was 10 weeks and they were all male. The histological slides had 4 μm thick
liver tissue with hematoxylin and eosin (H&E) staining. An inverted fluorescence microscope
(Nikon Eclipse), equipped with a digital camera was used to capture images. The images were
acquired at 4X, 10X and 20X-magnification using Bioquant Osteo software. The total size of an
image was 1280X960 pixels. The images were captured such that they cover complete liver
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sample under observation. The slide was placed on the stage of the microscope and the stage was
shifted first horizontally and then vertically to capture all the regions of the sample. While
moving the stage, special attention was provided to the X and Y coordinates of the corner edges
of the previous position.

a

b

c

Figure 3-1. Liver histology images with different magnifications: (a) 4X, (b) 10X and (c) 20X
for a mice-fed with a high-fat diet.
Generally, lipid droplets appear as white circular blobs with sharp edges on digital images but
all the pixels might not be completely white; some being pink in color (similar to background due
to staining) while other being grey (due to reflection, refraction or inadequate light of microscope
while imaging). In addition, there are other structures that are circular or appear white such as
sinusoids, portal veins, centrilobular veins or tissue cracks. Different structures present in liver
biopsy images that can confound the segmentation of FDs are shown in figure 2. These other
structures need to be discarded while segmenting the FDs. Moreover, the close-by FDs can
sometimes attach with each other and lose their circular shape as shown in Figure 2. A pseudo
code to segment FDs is presented in Figure 3.
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Figure 3-2. Image at 10x magnification showing different regions in liver histology. The
yellow boxes are non-fat white regions. The green boxes show attached FDs that do not
appear circular. The red box represents large white region which cannot be discarded by
thresholding and size constraint is imposed for not considering it during segmentation.
Thresholding and small objects removal
As the fat vacuoles appear white, they have high intensity value and can be segmented out
from other regions by using thresholding. The images had different brightness conditions so
manually picking a value did not work. Otsu’s method 61 which works by minimizing the intraclass variance of black and white pixels, was implemented (function threshold_otsu() in Figure
3) to automatically fix the threshold based on the characteristics of the image using skimage
library in Python (Python Software Foundation). The tiny circular white droplets, which occur as
a residual of thresholding operation could be falsely considered as lipid droplets and were
discarded by removing objects smaller than a threshold value (function small_objects_removed()
in Figure 3).
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Figure 3-3. Pseudocode for segmentation of FD
Morphological Operation

The images were then processed using morphological erosion and dilation operation
(function morphological_erosion() and morphological_dilation() in Figure 3). The operation was
applied iteratively until all the droplets were segmented. In each iteration following values were
modified:
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1. Structure disk size was increased.
2. Minimum object size to be discarded and maximum object size to be considered was
reduced.
3. The maximum eccentricity value was decreased, and the minimum roundness value was
increased.
To extract FDs that coalesce into single blobs and does not appear circular, morphological
operation with structure size=n-1 for dilation and structure size=n for erosion was used as shown
by dilate <- morphological_dilation(erode, disk_size-1) in pseudocode (Figure 3). Later while
segmenting FDs, the eroded image was dilated with structure size=n.
Segmenting Lipid Droplets
After each iteration of morphological operation, all the regions were checked against their
eccentricity, roundness value and area change after morphological operation. Eccentricity shows
how uncircular an object is, so region with eccentricity value less than a threshold value (te) was
preferred while objects with roundness value greater than a specific value (tr) was chosen. The te
and tr depended upon the magnification of image. With later iterations, structure disk size for
morphological operation increased. The higher disk size can produce circular objects from noncircular ones by removing long elongated portion of it. To account for this, its change in area
after the operation was computed and it was rejected if the change was higher than expected
(differed with magnification of image). All of these details has been represented abstractly by
round() function in the pseudocode (Figure 3). Finally, the regions that passed all these tests
were considered as FDs. In the pseudocode shown in Figure 3, the selected_objects list
represents a list of objects/regions selected as FDs.
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Results
By using the thresholding and morphological operation to the H&E stained liver histology
images, segmented image along with the number of FDs and FF were obtained in an automated
manner. Otsu’s method for thresholding was tested on grayscale image as well as red, green and
blue channels individually and was found that thresholding worked better on grayscale images.
The results obtained from the automated segmentation indicated that FF of the mice liver
specimens ranged from 0.05 to 11.5% with a mean of 5.37±2.79%. The segmented images were
verified qualitatively by pathologist but in the absence of ground truth segmentation result no
numeric value for the accuracy of the segmentation could be computed.
Figure 4 shows the segmentation result for 4X, 10X and 20X images. The 4X images
provided wide field of view but the FDs were tiny and difficult to be picked by the segmentation
algorithm as shown in Figure 4a where there are unpicked FDs. In contrary, for 20X images the
FDs were big, and a clear boundary of FD helped to improve the accuracy of algorithm (Figure
4c). The 10X images had a balance of area coverage and FD details as demonstrated by Figure
4b.

a
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c

Figure 3-4. Segmented Images. The yellow region represents the discarded region and grey
circular objects represent FDs. (a) 4X with 699 FDs and 5.74% FF. (b) 10X with 167 FDs and
4.87% FF. (c) 20X with 66 FDs and 8.78% FF.
Discussion and Limitations
Quantification of hepatic steatosis is a difficult task. Our visual system is well suited in
analyzing structure and distinguishing them but designing computerized technique to do so is
challenging. Our technique was able to segment FDs with qualitative validation from pathologist.
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In our method, thresholding played an important preliminary role by eliminating the background
pixels as well as disjoining close FDs. Morphological operation polished the process by enabling
the detection of coalesced FDs that were weakly connected. When the disk size was increased,
its degree of disconnection increased and it separated FDs that were joined along a larger arc that
led to the loss of their circularity and hence, allowed choosing them as separate fat bubbles.
However, this process could produce circular structure from elongated sinusoids or tissue cracks.
This was partially resolved by analyzing the area change after the operation.
The implementation was able to exclude larger white regions as well as white circular non-fat
objects. It also succeeded in capturing the joint FDs that do not appear as circle. To separate
connected lipid vacuoles, different structure size for opening and dilation was used. This well
suited the purpose, but it generated minor deviations from original size of the droplets. The
combination of roundness and eccentricity increased true positive. Sinusoids that are U-shaped
can have less eccentricity, but they get rejected by the roundness threshold.
Proper analysis of the segmentation of FDs can be useful to understand the pattern and
characteristics of them which will help to estimate the morphology of lipid droplets in different
pathologies.
There are some limitations in this study. Firstly, the maximum FF that could be obtained
from the liver samples were less than 15% which is not sufficient to cover the entire clinical
range of hepatic steatosis. Secondly, this segmentation method needs to be tested with higher
FFs. In addition, this segmentation technique was not cross validated with more rigorous manual
segmentation by pathologists such as manual point counting.

22

Chapter 4 Characterization of Hepatic Steatosis – Gamma Distribution Function
Introduction
Several studies have been conducted to study the properties of FDs with an objective to
detect FDs and quantify FF as well as number of FDs in liver. Characteristics of FDs is important
to mimic realistic hepatic steatosis that can serve as an alternative technique to analyze MRI
relaxivity. However, as per our knowledge, no study has used the properties of FDs to simulate
hepatic steatosis. Some studies have analyzed the circular morphology and smooth edge contour
of fat globules 57 while others have compared the shape of clustered and separate FDs with other
empty spaces 62 to identify FDs. Moreover, area and diameter of FDs has previously been
quantified to distinguish them from other white regions 53 Also, a strategy to lay a square tile
over liver biopsy image has been previously implemented to evaluate the regional inflammation
accumulation 63
Prior work has been successful to quantify FF with high accuracy and distinguish different
structures present in liver 53,57,62. They have analyzed the shape and eccentricity of FDs and
classified them based on their organization. However, they have mostly been qualitative analysis
because of limited number of clinical specimens. Hence, the objective of this research was to
quantify the size of FDs and position of FDs with respect to each other and perform statistical
modeling of those quantities to build a virtual model of hepatic steatosis mimicking true
histology that can serve as an alternative platform for further experiments related to steatosis.
Materials and Methods
Histological analysis
The segmented images in Chapter 2 were used to analyze the morphology and clustering
behavior of FDs by calculating their radius, inter-particle distance and inter-regional variation
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(regional anisotropy) in a liver specimen. The “skimage” library’s measure.regionprops function
was used to get those values. The pixels whose value differs by ~1 and are connected are
considered as a single region by the function. It provides the minor axis as well as the major axis
of the region; the length of the minor axis was considered as the radius of the region.
To estimate the inter-particle distance, nearest neighbor (NN) distance was considered. The
NN distance shows how the droplets are present with respect to each other that indicates the
separation between them as well as their tendency to arrange in group. In actual liver, FDs are
distributed by 3D NN distance but as we had 2D images of liver biopsy 2D NN distance was
computed by first tracking the centroids of each FDs, then calculating the distance between the
centroid of each FD with that of other FDs and finally evaluating the shortest distance between
them.
For analyzing the accumulation of FDs within certain region (regional anisotropy), 120 μm
side square grid, roughly six times the mean hepatocyte dimension, was laid over the segmented
image. Then the amount of FF within each region was calculated and normalized to the
maximum value for each image, i.e. the scale of histogram in X direction was set in the range [0,
1].
Statistical Description
To examine the relationship between FF and the characteristics of the FDs, a generalized
Gamma Distribution Function (GDF) was selected because it is flexible such that Chi-square,
exponential, Erlang and Weibull distributions are special case of it, obtained by different
combination of the parameters. A GDF has two parameters: shape (𝛾) and scale (β). Generally,
the 𝛾 parameter defines the height of the distribution and β parameter is related to its width
(Figure 1). The GDF can be expressed as,
24

𝑥−𝜇 𝛾−1

1

𝐺𝐷𝐹(𝑥) = 𝛽∗Γ(𝛾) ∗ ((

𝛽

)

𝑥−𝜇

∗ exp (

𝛽

))

(1)

where, 𝜇 is the location parameter. 𝛽 > 0, 𝛾 > 0, 𝑥 ∈ [0;∞), 𝑥 ≥ 𝜇 and Γ(𝛾) is the Gamma
function evaluated at 𝛾 given by,
∞

Γ(𝛾) = ∫0 𝑡 𝛾−1 𝑒 −𝑡 𝑑𝑡

(2)

The gamma function in Eq. 2 is generally used as an extension of the factorial function to
real and complex numbers. The GDF in Eq. 1 was used to model the properties (radius, NN
distance and regional anisotropy) of lipid droplets at different fat concentrations. For this
purpose, the location parameter 𝜇 was considered to be 0, i.e., standard gamma distribution.

Figure 4-1. Gamma Distribution Function (GDF) with different shape and scale parameter
After representing each properties of FDs with their respective GDF, the gamma parameters
of each distribution were generalized with respect to FFs using regression analysis.
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Model Generation
To simulate a liver volume, a cuboid of 600X600X120 μm3 dimension was designed. The fat
vacuoles were placed as a spherical impenetrable ball in the simulated environment until the
desired FF was reached. No other anatomical structures such as sinusoids were considered for
the simulation. To generate a sphere, its size was estimated from lipid droplet size histograms.
The spheres were distributed in two different ways:
1. Random Distribution
Pseudocode to simulate random distribution of FDs is shown in Figure2. The generated fat
spheres were placed in the virtual environment using Gaussian random distribution. They were
not allowed to overlap with each other and if a collision was detected (function collision() in
figure 2) then the FD was placed on the boundary of the colliding FD (function
surface_colliding_fd() in figure 2) and the collision test was repeated until the collision was
resolved or a specified number of attempts were made. A new random position for the FD was
generated (function random_location() in figure 2) if the collision was still present after the
specified attempts and the process was repeated.
2. Distribution based on regional anisotropy with NN distance
The virtual environment was like (a), but the FDs were placed according to the GDF of the
NN distance with respect to each other within the 120 μm region. The FF in each region 120 μm
was determined using the GDF of the regional anisotropy. First FD was placed randomly then
every next FD was placed at NN distance, provided by the inter-particle histogram, from the
previous FD. Collision was checked like (a) with additional resolving measures. If collision
could not be resolved within specified attempts, then a new NN distance was generated, and the
sphere was placed without changing the reference sphere. If the collision still existed after
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certain iterations, then a new reference sphere was chosen, and the process was repeated. Finally,
to avoid infinite attempts, if collision was still present then the sphere was positioned in a new
random location.
The simulation model was shown as a three-dimensional liver volume using the best GDF
parameters. To validate the distribution of FDs using the model, virtual 4 μm thick 2D crosssections were visually compared with the corresponding true histology tissue images.

Figure 4-2. Pseudocode to simulate hepatic steatosis using random distribution of FDs
27

Results
Microscopy Analysis
The size and distribution of lipid droplets were examined from sixteen segmented images.
Figure 3(a) is an image collected from the microscope at 10X of a liver biopsy specimen with FF
9.48%. The magnification helped to capture the variations in FDs. Figure 3(b) shows regions in
original image selected as FDs. The images were segmented as described in Chapter 2 using
thresholding and iterative morphological operation. The information extracted from these images
are listed below.

a

(c)

(b)
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Figure 4-3. Histology image collected from the microscope at 10X magnification of a liver
biopsy specimen with FF of 9.48% (a), and segmentation mask of FDs laid over the original
image (b). The FDs are depicted as white circular objects
(a) Cellular lipid droplets size distribution
The radii of the lipid droplets for different FFs were extracted from the segmented masks and
their histogram was plotted with the fitting of corresponding GDF. Figure 4a represents the
histogram for three representative liver samples with different FFs. As FF increases the peak of
the histogram moves towards right indicating increase in number of FDs with larger size.
The shape (γ) and scale (β) parameter of GDF were fitted by doing regression analysis with
respect to FF. β showed a linear trend and moderate correlation with FF, β = 0.0809*FF+0.3188
(R² = 0.490) as shown in Figure 4b. The γ parameter showed a strong linear relationship with the
β parameter of GDF, allowing to accurately estimate its value using the equation γ = -13.254*
β+23.144 (R2=0.819), which is shown in Figure 4c.

29

a

b

30

c

Figure 4-4. Lipid droplet size distribution: (a) The graph demonstrates the relative frequency
of lipid droplets as a function of their radii for three different FFs of liver sample. It shows that
the size gets bigger with increase in FF. Linear regression plots show the relationships between
β and FF (b) and γ and β (c).
(b) Inter-particle distance
NN distance was calculated as shown by yellow lines in Figure 5a. After analyzing the
distance between all FDs, the shortest distance was chosen. The NN distances between the FDs
were calculated and their histogram was plotted as shown in Figure 5b. The plot shows that as
the FF increases the FDs are more tightly packed. Figure 5c demonstrates that the β parameter of
the NN GDF is moderately corelated to the FF (R² = 0.5241) for linear regression and is
represented by β = -0.7777*FF+10.259. The γ parameter had a similar linear relationship with
FF, given by γ = 0.7535*FF + 3.8343 (R2=0.4845) as shown in Figure 5d. However, it had
comparatively strong relationship (R² = 0.7254) with β parameter of the GDF, shown by Figure
5e, which enabled more accurate computation using the relationship 𝛾 = -0.8583*β + 13.116.
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Figure 4-5. Inter-particle distance: (a) Image showing NN distance estimation between FDs
after automatic segmentation. (b) The graph demonstrates the NN distance histogram for three
different FFs of liver specimens. It indicates that as the FF increases the distance between FDs
decreases. (c) The plot shows the relationship between β and FF. (d) The graph shows how γ is
correlated with FF. (e) The plot shows how γ varied with β.
(c) Regional Anisotropy
Regional anisotropy is the difference in deposition of FDs among regions in liver biopsy
image. For regional anisotropy, the distribution followed an exponential curve for low FF due to
the absence of fat deposition in most of the regions. With increase in FF, the distribution shifts
towards right showing more regions with higher FF (Figure 6a). The β parameter is weakly
correlated to the FF (R² = 0.27) showing a linear relationship represented by 𝛽 = 0.009 ∗ 𝐹𝐹 −
0.0049 (Figure 6b). The γ parameter demonstrated a moderately correlated exponential
relationship (R² = 0.56) with the β parameter of the GDF given by 𝛾 = 3.5949 ∗ 𝑒 −18.98∗𝛽
(Figure 6c).
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Figure 4-6. Regional Anisotropy. (a) The graph demonstrates the regional anisotropy histogram
for three representative FFs of liver specimens. It indicates that as the FF increases the number
of regions with the absence of fat deposition decreases. (b) The plot shows the relationship
between β and FF. (c) The graph shows how γ is correlated with β.
Simulated Liver Model
A comparison of model generated fat morphology and actual histological sample using two
different distributions of FDs for FF of 8% is shown in Figure 7. The 3D cuboid represents a
600X600X120 simulated liver geometry with FDs shown as white spheres (Figure 7a and 7b). A
random 4μm thick cross-sectional view of the corresponding volume is represented in Figure 7c
and Figure 7d along with histology specimen in Figure 7e. Random Distribution of FDs does not
show realistic accumulation of FDs. Implementation of nearest neighbor statistics helps to mimic
the grouping characteristic of FDs and regional anisotropy distributes the accumulated FDs
among different regions. Note that all the regions of predicted morphology for regional
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anisotropy with NN does not have equal volume of FDs and demonstrate in-vivo clustering
behavior of FDs.

Figure 4-7. Model predicted fat morphology with 8% FF in a 600X600X120 liver volume.
Random (a) and regional anisotropy with nearest neighbor (b) distribution of FDs (depicted as
white spheres) in 3D liver geometry and corresponding 4μm thick random sections of the 3D
models (c, d), and actual histological section with 8.16% FF (e). Note the similarity between (d)
and (e). The FDs in (e) are seen around a large white vacuole. Similar clustering behavior is
shown by FDs in top left quarter of (d) (large white vacuole not shown).
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Discussion and Limitations
The main aim of this study was to create a statistical model to describe the size and
morphology of FDs in tissue. Accurate simulation of morphology of FDs will help to mimic
synthetic MRI signals in the presence of fat and analyze the 𝑅2∗ decay curves for different FFs. In
this research, the method of statistical modeling was experimented with low FF and data from
mice with hepatic steatosis. But this technique can be generalized to higher FF and be applied to
other diseases associated with fat accumulation such as fibrosis and cirrhosis.
The size, inter-particle distance and inter-region variation of FDs could be well characterized
by GDF but it failed while modeling regional anisotropy for FF less than 5%. It is because of low
FF that most of the FDs were accumulated in certain regions of liver sample leaving large
portions of it with no fat. This caused the distribution data to be mostly zero. The GDF for low
FFs using 120X120 square grid showed that almost 65% of the region had no fat accumulation.
It also demonstrated that such region is decreasing with increase in FF which is a positive sign
that regions with no FF are encountered less at higher FFs. This suggests that more robust
relation between regional anisotropy and FF can be generated with wide FF range.
This work assumes 2D distance between FDs for measuring inter-particle distance but in reality,
the FDs are in 3D space and for more accurate estimation of NN distance, 3D environment
should be considered. Nevertheless, this approach successfully simulated hepatic steatosis to any
given FF within the range 0%-13% that showed resemblance to actual histology. The range of
simulation is limited by the regression equations estimated for size and NN analysis at only low
FFs. We believe that the simulation can be expanded to create steatosis models with wide clinical
FF ranges by performing this experiment with variety of samples including low to high FFs.
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Chapter 5 Relaxivity-Fat Calibration in Hepatic Steatosis: Design of a Monte Carlo Model
Introduction
Recent development in MRI has increased its clinical acceptance as a non-invasive technique
to assess hepatic steatosis. Further, single and dual 𝑅2∗ MRI models have been proposed for
quantification of FF but there is no common consensus between these two models and current
data is limited for which model is accurate to quantify FF.
To understand the relationship between relaxivity and FF and determine a signal model for
accurate estimation of FF and 𝑅2∗ , we use a computational procedure to produce a realistic liver
volume with hepatic steatosis. The liver geometry was used to mimic desired FF (as discussed in
Chapter 4) and MRI signal is simulated at field strengths of 1.5T and 3.0T using Monte Carlo
modeling. Competency of such model to predict 𝑅2∗ -iron relationship has previously been
demonstrated 64. In this research, we have modified the model and simulated steatosis to explore
𝑅2∗ -FF relationship as well as prediction of FF and 𝑅2∗ at different field strengths using multispectral fat-water models.
Monte Carlo simulation is employed by modeling possible magnetic field inhomogeneities
and mobility of water protons in liver. Water proton’s mobility is considered as free random
isotropic movement across the simulated geometry which causes change in angle to the magnetic
axis and distance from the surrounding FDs resulting in random effect of magnetic field from
FDs. To mimic realistic magnetic field inhomogeneities, spheres representing FDs are placed as
described in Chapter 4. Rather than choosing average radius for the spheres, radii are chosen
from a distribution representing the size of FDs extracted from liver biopsy images. All of these
affects the total accumulated phase and consequently helps in simulating realistic MRI signal.
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Materials and Methods
Virtual liver environment was created using the relationships generated in Chapter 4. FDs
were placed in the liver volume using random and regional anisotropy with NN analysis-based
distributions. The following were the relationships between GDF parameters and FFs derived in
Chapter 4.
Table 1. Equations representing FD morphology
FD Features
Radius
NN Distance
Regional Anisotropy

Equation
𝛽 = 𝑚 ∗ 𝐹𝐹 + 𝑐
𝛾 =𝑚∗𝛽+𝑐
𝛽 = 𝑚 ∗ 𝐹𝐹 + 𝑐
𝛾 =𝑚∗𝛽+𝑐
𝛽 = 𝑚 ∗ 𝐹𝐹 + 𝑐
𝛾 = 𝑚 ∗ 𝑒 𝛽∗𝑐

m
0.0809
-13.254
-0.7777
-0.8583
0.009
3.5949

c
0.3188
23.144
10.259
13.116
-0.0049
-18.98

R2
0.49
0.82
0.52
0.73
0.27
0.56

A total of 10,000 water protons were distributed randomly in the generated liver volume. The
protons were allowed to perform three-dimensional Brownian motion but they were restricted to
pass through the FDs. As the protons moved freely, they accumulated phase depending on their
movement because their phase would be affected by their position relative to FDs. Water and fat
signals were calculated separately, and total signal was computed by the superposition of signals
from all the protons. The computerized mathematical model to simulate MRI signal has been
discussed below.
Monte Carlo Model for MRI Signal Synthesis and 𝑅2∗ Analysis
The magnetic dipole field equation for each FD is calculated using,
∆𝐵(𝑟, 𝜃) =

𝐵0
3

𝑅 3

𝜒 ( 𝑟 ) (3 cos 2 𝜃 − 1)

(1)

where B0 is the applied magnetic field, 𝜒 is the FD susceptibility, R is the sphere radius, r is the
radial distance between the center and the observation point and θ is the azimuthal angle to the
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magnetic axis. A total of 10,000 water protons were distributed randomly in the liver volume and
their mobility was characterized by Brownian motion with mean displacement given by,
𝜎 = √2𝐷𝛿

(2)

where D is the diffusion coefficient (D=0 for FD/iron and 0.76 µm2/ms for water protons in
human liver (65) and 𝛿 is the time-step, which was taken as 0.5µs. The simulation was continued
for 15ms and total phase accrual, for each proton, at time step t was given by,
∅(𝑡) = 𝛾𝛿 ∑𝑡𝑖=1(𝐵0 + ∆𝐵(𝑝(𝑖)))

(3)

where 𝛾 =2.675*108 rads-1T-1 is the gyromagnetic ratio and 𝑝(𝑖) is the proton’s position at ith
time-step. The phase was assumed same for fat and water protons and the complex signal for a
single proton was computed as,
𝑆𝑊 (𝑡) = 𝑆(0)𝑒 −𝑡𝑅20+𝑗∅(𝑡)

(4)

𝑆𝐹 (𝑡) = 𝑆(0)(∑𝑃𝑝=1 𝛼𝑝 𝑒 𝑗2𝜋𝑓𝐹,𝑝 𝑡 )𝑒 −𝑡𝑅20+𝑗∅(𝑡)

(5)

where R20 is the relaxation in normal liver and was empirically assumed to be 20s-1 at 1.5T and
35s-1 at 3.0T, 𝑓𝐹,𝑝 are the frequencies for the multi-peak fat spectra relative to water peak and 𝛼𝑝
are the relative amplitudes of the fat signal. The total synthesized signal was obtained by the
superposition of signals from all protons,
𝑆(𝑡) = 𝑆𝑤 (𝑡) + 𝑆𝐹 (𝑡)

(6)

The MRI signal relaxation and FF for different steatosis ranges was calculated using multispectral fat-water techniques by implementing it on the complex total synthesized signal. The
NLSQ model was implemented from the ISMRM Fat-Water Toolbox (FWT) that estimates the
B0 field map with the application of the graph cut algorithm. It assumes a single 𝑅2∗ for water
and fat peaks and uses published values for the relative frequencies of both the peaks, and for the
relative amplitudes of the lipid peaks 66. The Auto Regressive Moving Average Model (ARMA)
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was implemented as an iterative approach, similar to 67, starting with the maximum number of fat
peaks (6 peaks) plus a water peak (i.e. 7 peaks) and reducing the number of peaks iteratively
until the frequencies of the detected lipid peaks fell within the range of the reported relative
frequencies (± 0.5 ppm) 66.
Comparison with true relaxivity
The 𝑅2∗ value predicted by the simulation using different 𝑅2∗ models at different FFs were
compared against the in vivo 𝑅2∗ -FF calibration curve at 3.0T
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using Bland Altman plot to

determine the effect of fat on 𝑅2∗ .
Results
Magnitude Signal
Figure 1 shows the difference in synthesized signals generated at 1.5T and 3.0T for 12% FF
and 𝜒 = 0.3 ppm where the FDs were placed based on regional anisotropy with NN distribution
of FDs. The signals had steeper decay at 3.0T compared to 1.5T because of increase in magnetic
field strength. The plot of the total signal showed that fat and water were in phase for every
4.6ms at 1.5T and 2.3ms at 3.0T (i.e. 4.6ms, 9.2ms, 13.4ms, etc. at 1.5T and 2.3ms, 4.6ms,
6.9ms, etc. at 3.0T). Also, it depicted that the signals had opposed phase starting at 2.3ms and
1.15ms at 1.5T and 3.0T respectively. These Echo Time (TE) values match the known values for
corresponding field strengths.
Figure 2 compares the total synthesized signal (magnitude only) between random distribution
and regional anisotropy with inter-particle distance-based distribution for 12% FF, 𝜒=0.3ppm at
1.5T and 3.0T. The signal showed similar pattern for both the distribution at 1.5T throughout the
simulation time whereas the signal at 3.0T demonstrated steeper slope for regional anisotropy
with NN distribution compared to random distribution in the later time-steps. Figure 3 plots total
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synthesized signal at 1.5T and 3.0T for both types of distribution of FDs to differentiate the
signal at various FF (5%, 8% and 12%). As FFs increased, the amplitude of fat-water oscillations
increased as predicted.

Figure 5-1. Water, fat, and total synthesized magnitude signals for FF = 12% and 𝜒 = 0.3 ppm.
a-c represents 1.5T and d-f represents 3.0T. The TE values matched that of published results.
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Figure 5-2. Random Distribution vs RA+NN based distribution of FDs using total synthesized
magnitude signal for 12% FF and 𝜒 =0.3 ppm at 1.5T (a), and 3T (b). The signal decays are
similar for both distributions at 1.5T but RA+NN distribution is slightly faster at 3 T.

Figure 5-3. Total synthesized signal for different FFs (5%, 8% and 12%), 𝜒 = 0.3ppm and both
FD distributions at 1.5T and 3T. (a) Random Distribution at 1.5T, (b) RA+NN based distribution
at 1.5T, (c) Random Distribution at 3.0T and (d) RA+NN based distribution at 3.0T.
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MRI Relaxivity analysis
The relaxivity depends upon the susceptibility of fat. BA analysis for water 𝑅2∗ predictions at
different susceptibility ranged from -0.3 to 1.4 ppm with respect to in vivo calibration obtained
from patients with the absence of iron overload at 3.0T 68is summarized in Table 2. Overall, the
analysis showed that the predictions were evenly distributed around the bias (the mean difference)
for the models regardless of the distribution. Both models have bias closest to 0 and thin width of
limits of agreement (LOA) for 𝜒 = 0.4ppm for random distribution. Among them FWT showed
excellent prediction with mean difference of 1.0s-1 (SD=0.9s-1) between reference and predicted
𝑅2∗ value. For regional anisotropy with NN based distribution, ARMA model produced best
outcome with bias = 0.2s-1 (SD=0.5s-1) for 𝜒 = 0.3ppm. The predicted susceptibility of 0.3ppm is
within the 95% CI of the in-vivo susceptibility value 0.10 ± 0.14ppm 69. So, for rest of the paper
susceptibility of FD is considered as 0.3ppm.
Figure 4 plots the water relaxivity estimated by ARMA and FWT model for different FF at
1.5T and 3.0T for random and regional anisotropy with NN based placement of FDs. The plot
depicts that the 𝑅2∗ of water increases linearly with FF. For 3.0T, the predicted relaxivity values
were within 95% CI and regional anisotropy with NN based distribution of FDs agreed more with
the in-vivo calibration as shown by BA analysis (Table 2). Generally, ARMA predicted higher 𝑅2∗
value as compared to FWT. Similarly, water 𝑅2∗ value predicted for regional anisotropy with NN
based distribution is higher than that for random distribution of FDs which brings it to only 0.2s-1
below the in-vivo calibration from 1.5s-1, according to BA analysis.
Figure 5 shows fat-𝑅2∗ estimated by ARMA model for both distribution of FDs at 1.5T and
3.0T. FWT did not predict 𝑅2∗ value for fat because it assumes single relaxation for both fat and
water. At lower field strength, the relaxivity of fat did not show any pattern but at 3.0T linear
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trend was observed similar to water-𝑅2∗ . The fat relaxivity also demonstrated pattern similar to 𝑅2∗
of water for regional anisotropy with NN based distribution where fat-𝑅2∗ is generally higher than
that for random distribution of FDs.
Table 2. Bland-Altman analysis between 𝑅2∗ values predicted using both models at different
susceptibilities versus 𝑅2∗ values obtained from the in vivo calibration at 3T.
𝝌 (ppm)
-0.3
-0.2
-0.1
0.1
0.2
0.3
0.4
0.5
1
1.4

𝑹∗𝟐 Models
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT
ARMA
FWT

Random distribution
Bias (s-1)
SD (s-1)
1.4
0.8
2.1
1.2
3.6
2.0
3.8
2.3
5.1
2.8
4.6
3.0
5.0
2.7
4.6
3.0
3.5
1.9
3.8
2.3
1.5
0.8
2.1
1.2
-1.2
0.7
-1.0
0.9
-1.4
2.4
-4.0
2.0
-22.2
12.0
-21.9
12.1
-35.9
19.7
-35.9
19.5
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RA+NN based distribution
Bias (s-1)
SD (s-1)
0.3
0.5
0.7
0.7
2.8
1.3
3.2
1.8
4.9
2.6
4.6
3.0
4.9
2.6
4.6
3.0
2.9
1.4
3.2
1.8
0.2
0.5
0.7
0.7
-3.3
2.5
-3.0
2.4
-7.1
4.8
-6.8
4.7
-26.2
15.8
-26.2
15.7
-38.4
22.1
-38.2
22.3

Figure 5-4. Predicted water relaxivities for different 𝑅2∗ models for 0-13% FF and 𝜒 = 0.3ppm at
1.5T and 3.0T. Overall, 𝑅2∗ showed linear increment with FF. Regional Anisotropy with NN
distribution showed higher degree of agreement with in-vivo calibration.

Figure 5-5. Different 𝑅2∗ models predicted fat relaxivities at 0-13% FF and 𝜒 = 0.3ppm at 1.5T
and 3.0T. No pattern was seen at 1.5T but linear trend could be seen at 3.0T.
FF analysis
Figure 6 demonstrates a comparison of FF predicted from 𝑅2∗ models with simulated FF for
both distributions of FDs at 1.5T and 3.0T. The dotted line shows the line of agreement between
them. ARMA model underestimated the FF values at 1.5T and overestimated it at 3.0T.
Comparatively, FWT showed greater agreement with the simulated FF for all analyzed cases.
This plot shows that both the relaxivity models predict FF with high degree of accuracy.
47

Figure 5-6. Comparison of predicted FF with simulated FF for both distributions and 𝜒 = 0.3ppm
at 1.5T and 3.0T. The dotted line is the line of unity which shows the point where the two values
will be equal. FWT predicted excellent FF result for both distribution of FDs. ARMA seem to
estimate lower FF values at 1.5T and higher FF values at 3.0T.
Discussion and Limitations
In this work, we used a Monte Carlo model to synthesize MRI signal and analyze the FF as
well as relaxivity of fat and water at different field strengths using FWT and ARMA models. The
presence of lipid droplets impacts 𝑅2∗ of MRI signal. Although the magnetic susceptibility of fat is
relatively small in comparison with iron, it can generate small field inhomogeneity which can
increase the signal decay rate resulting to higher 𝑅2∗ 70. Our work demonstrates that there was
increase in decay rate of MRI signal with increase in FF which suggests that fat produces field
inhomogeneity.
There is a strong cooccurrence of NAFLD along with hyperferritinemia and mild iron overload
71

. The susceptibility of iron is very high compared to that of fat. So, quantifying fat susceptibility

in the presence of iron is difficult and proper analysis of fat susceptibility has not been done yet.
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For estimating the susceptibility of fat, we analyzed the relaxivity of fat and water as well as FF at
∗
different fat susceptibilities -0.1 to 0.5 ppm and 1 ppm. Then, evaluated i) 𝑅2,𝑊
with in vivo

calibration and ii) predicted FF with true simulated FF at those susceptibilities. The BA analysis
and line of unity analysis produced excellent result for 𝜒 = 0.3ppm which is within 95% CI of the
in-vivo calibration (0.10±0.14ppm) 69. Hence, this method was able to estimate the susceptibility
of fat with acceptable accuracy. Susceptibility of 0.5ppm predicted by Monte Carlo modeling is
reported in 72. The difference might be because they have simulated FDs with constant radius using
random distribution.
The 𝑅2∗ values of water predicted by ARMA and FWT model were within the 95% confidence
bound for both distributions of FDs but the values for regional anisotropy with nearest neighbor
distribution of FDs were comparatively closer to the in-vivo calibration at 3.0T for 𝜒 = 0.3 ppm.
Also, this result was validated by BA analysis. This shows that both the distributions of FDs were
able to simulate hepatic steatosis and mimic MRI signal with acceptable accuracy (BA analysis,
random distribution: 1.5±0.8 and regional anisotropy with NN distribution: 0.2±0.5) but the
distribution with regional anisotropy and nearest neighbor was superior by being able to simulate
in-vivo characteristic of FDs.
The ARMA models consider different 𝑅2∗ for fat and water and should be able to estimate the
FF with higher accuracy as compared to FWT (single 𝑅2∗ ) but it is not stable at low FF and FF
quantification accuracy decreases 52. This work supports the result published in

52,73

and shows

that single 𝑅2∗ model is better for quantifying FF. However, our findings related to different
relaxivity of fat and water (29.97±0.63 s-1) for ARMA model contradicts the result reported in 52.
They observed that both relaxivities were very similar with mean difference of 0.95±8.28 s-1. We
∗
∗
found similar 𝑅2,𝐹
and 𝑅2,𝑊
(0.46±0.88) for 𝜒 = ±0.1 ppm where ARMA peak model was able to
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∗
identify all 6 peaks of lipid but 𝑅2,𝑊
predicted at 𝜒 = ±0.1 was not within 95% CI of in-vivo
∗
𝑅2,𝑊
calibration. The difference for 𝜒 = 0.3ppm might be because ARMA model was able to

identify only 2 fat peaks.
In the absence of high FF, the simulation could not mimic severe hepatic steatosis but this
study showed that the information of size of FDs, inter-particle distance and regional anisotropy
was useful to mimic steatosis and analyze 𝑅2∗ within 95% CI of the in vivo calibration. This
showed the feasibility of Monte Carlo modeling to mimic fat accumulation in liver. Simulation
of fat deposition in other organs could be achieved by using similar data about them. In addition,
it can be used to mimic steatosis of organs where liver biopsy is not possible by gathering that
information from autopsy specimens.
In summary, complete knowledge of size and location of FDs is required to mimic steatosis.
We were able to predict in vivo human water relaxivity within 95% CI using the radius and
distance between closest FD neighbor from mice liver sample. In addition, we used it to estimate
the susceptibility of fat in liver. The result can further be improved by conducting the experiment
with human liver sample that covers entire clinical range of FF and improving the ARMA 7 peak
model to identify all 6 lipid peaks.
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Chapter 6 Conclusion
MRI provides a non-invasive tool to monitor hepatic steatosis 3,4,48 but it is still under
research. Studies have used single and dual 𝑅2∗ to quantify FF but there is no common agreement
about which 𝑅2∗ model is superior to other. 𝑅2∗ -FF relationship must be analyzed further to
increase the clinical acceptance of MRI. It is difficult, tedious and expensive to recalibrate the 𝑅2∗
estimates in large patient population representing entire FF clinical range.
The primary objective of our study was to develop an alternative approach to recalibrate the
FF-𝑅2∗ relationship and to determine the accuracy of single and dual 𝑅2∗ models. Our hypothesis
states that the in vivo FF-relaxivity relationship can be estimated using Monte Carlo modeling
provided the morphology, location and susceptibility of FDs, water proton mobility in tissue and
𝑅2∗ model. This approach can reduce or eliminate the need of patient population for recalibration.
In addition, it can be used to study other phenomenon related to steatosis.
Original Contributions
The innovations of this study are:
1. Automatic segmentation of FDs has been done previously 55-57 but the morphology and
distribution pattern of FDs based on FF have never been quantified. This study has analyzed
those characteristics of FDs and developed a statistical model to represent them. This led a
foundation to simulate hepatic steatosis with desired FF. Also, it provided information about
the size and distribution of FDs in liver.
2. Monte Carlo modeling for mimicking steatosis with properties of FDs extracted from liver
biopsy samples is used for the first time. In this work, we used the simulation to study the
effect of fat deposition on MRI relaxivity for different field strengths and 𝑅2∗ models. Fat
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deposition differs with tissue so we believe that tissue specific statistical models can be
generated and this approach can be used to build tissue specific simulations.
Findings
Our work has demonstrated the potential of using computerized technique to examine the FF𝑅2∗ calibration. The size and inter-particle distance of lipid droplets for different FF was obtained
from liver biopsy specimens of mice. Gamma Distribution Function was used to represent those
characteristics. GDF proved to be a suitable fit for modeling them by showing expected
variations corresponding to the features of FDs. For example: GDF showed increment in size of
FDs as we move to higher FF which is a well implied result. The larger volume of the droplets
contributed to increase in FF. In addition, the shape and scale parameters of GDF showed good
correlation with FF. Hence, we can conclude that GDF was able to characterize the FDs
appropriately and demonstrated to be a good choice.
With the simulation of hepatic steatosis using statistical models, Monte Carlo modeling was
used to generate MRI signal in the virtual environment. We were able to generate realistic MRI
signals and analyze the effect of FDs on the MRI relaxivity. We used single as well as dual 𝑅2∗
models for the analysis. The 𝑅2∗ of both fat and water was found to increase linearly with FF
which agreed with published result 70. The in-phase and opposed-phase cycle of the simulated
signals matched that of known values. Also, the relaxivity values of water at 3.0T field strength
were within 95% confidence bound of in-vivo calibration and had mean offset of -1.5±0.8 and
0.2±0.5 from true values for random and regional anisotropy with NN distribution respectively.
This showed that Monte Carlo modeling successfully simulated the MRI signal in fatty liver.
This helped us to examine the susceptibility of fat in liver which is generally convoluted in the
presence of iron in human liver. Our experiment estimated the susceptibility of fat as 0.3 ppm.
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Also, our research showed that single 𝑅2∗ model is more accurate than dual 𝑅2∗ model for
quantifying FF. The steatosis simulation as well as Monte Carlo modeling can be used for other
similar examinations and analysis.
Future Works
We have successfully built a realistic hepatic steatosis 3D model and used it to estimate
single and dual 𝑅2∗ -FF relationship with acceptable accuracy but there are areas that still need
more attention. Some of them are discussed below.
1. The automatic segmentation of FDs from liver biopsy was validated qualitatively but was not
cross validated with more rigorous manual segmentation by pathologists such as manual
point counting. The cross validation can be used to test the accuracy of the segmentation.
2. The FFs in our liver samples do not cover the entire clinical range 0-50% 74. This study has
shown that realistic liver model can be generated for 0-13% FF. The techniques developed in
this study can be used to simulate steatosis for entire clinical range.
3. The relaxivities estimated by the Monte Carlo model are based on the true diffusion
coefficient (D) of water in tissues. The value of D depends upon tissue organization and fatproton interaction. The only published value of D for normal liver is 0.76±0.27 µm2/ms 65.
The value of D in the presence of fat is not known. The true value of D in fatty tissues can
help in accurate calibration of 𝑅2∗ values.
4. In this study, we have used mice liver samples and compared the predicted relaxivities with
human in vivo calibrations. The prediction of this method can be improved by performing
this experiment with human liver specimens. Also, the predicted relaxivities needs to be
compared with in vivo calibration at 1.5T.
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5. A strong co-occurrence of NAFLD along with hyperferritinemia and mild iron overload has
been reported 71. So, designing models simulating both steatosis and iron-overload can be
helpful to study the combined effect of iron and fat on MRI signal.

54

References

1. Younossi, Z.; Tacke, F.; Arrese, M.; Chander Sharma, B.; Mostafa, I.; Bugianesi, E.; Wai‐Sun
Wong, V.; Yilmaz, Y.; George, J.; Fan, J. Global perspectives on nonalcoholic fatty liver
disease and nonalcoholic steatohepatitis. Hepatology 2019, 69, 2672-2682.
2. Baršić, N.; Lerotić, I.; Smirčić-Duvnjak, L.; Tomašić, V.; Duvnjak, M. Overview and
developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World Journal of
Gastroenterology: WJG 2012, 18, 3945.
3. Idilman, I. S.; Aniktar, H.; Idilman, R.; Kabacam, G.; Savas, B.; Elhan, A.; Celik, A.; Bahar,
K.; Karcaaltincaba, M. Hepatic steatosis: quantification by proton density fat fraction with
MR imaging versus liver biopsy. Radiology 2013, 267, 767-775.
4. Tang, A.; Tan, J.; Sun, M.; Hamilton, G.; Bydder, M.; Wolfson, T.; Gamst, A. C.; Middleton,
M.; Brunt, E. M.; Loomba, R. Nonalcoholic fatty liver disease: MR imaging of liver proton
density fat fraction to assess hepatic steatosis. Radiology 2013, 267, 422-431.
5. Kühn, J.; Hernando, D.; Muñoz del Rio, A.; Evert, M.; Kannengiesser, S.; Völzke, H.; Mensel,
B.; Puls, R.; Hosten, N.; Reeder, S. B. Effect of multipeak spectral modeling of fat for liver
iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012,
265, 133-142.
6. Meisamy, S.; Hines, C. D.; Hamilton, G.; Sirlin, C. B.; McKenzie, C. A.; Yu, H.; Brittain, J.
H.; Reeder, S. B. Quantification of hepatic steatosis with T1-independent, T2*-corrected
MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy.
Radiology 2011, 258, 767-775.
7. Yokoo, T.; Bydder, M.; Hamilton, G.; Middleton, M. S.; Gamst, A. C.; Wolfson, T.;
Hassanein, T.; Patton, H. M.; Lavine, J. E.; Schwimmer, J. B. Nonalcoholic fatty liver
disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalledecho MR imaging at 1.5 T. Radiology 2009, 251, 67-76.
8. Reeder, S. B.; Robson, P. M.; Yu, H.; Shimakawa, A.; Hines, C. D.; McKenzie, C. A.;
Brittain, J. H. Quantification of hepatic steatosis with MRI: the effects of accurate fat
spectral modeling. Journal of Magnetic Resonance Imaging: An Official Journal of the
International Society for Magnetic Resonance in Medicine 2009, 29, 1332-1339.
9. Boxerman, J. L.; Hamberg, L. M.; Rosen, B. R.; Weisskoff, R. M. MR contrast due to
intravascular magnetic susceptibility perturbations. Magnetic resonance in medicine 1995,
34, 555-566.
10. Ford, J. C.; Wehrli, F. W. In vivo quantitative characterization of trabecular bone by NMR.
Magnetic resonance in medicine 1991, 17, 543-551.
55

11. Gillis, P.; Petö, S.; Moiny, F.; Mispelter, J.; Cuenod, C. Proton transverse nuclear magnetic
relaxation in oxidized blood: a numerical approach. Magnetic resonance in medicine 1995,
33, 93-100.
12. Weisskoff, R.; Zuo, C. S.; Boxerman, J. L.; Rosen, B. R. Microscopic susceptibility variation
and transverse relaxation: theory and experiment. Magnetic Resonance in Medicine 1994,
31, 601-610.
13. Coyle, E. F. Fat metabolism during exercise. Sports Science Exchange 1995, 8, 59.
14. Rapoport, S. I.; Ramadan, E.; Basselin, M. Docosahexaenoic acid (DHA) incorporation into
the brain from plasma, as an in vivo biomarker of brain DHA metabolism and
neurotransmission. Prostaglandins Other Lipid Mediat. 2011, 96, 109-113.
15. Finkelstein, E. A.; Khavjou, O. A.; Thompson, H.; Trogdon, J. G.; Pan, L.; Sherry, B.; Dietz,
W. Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 2012, 42, 563570.
16. Kahn, B. B.; Flier, J. S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106, 473-481.
17. Dash, A.; Figler, R. A.; Sanyal, A. J.; Wamhoff, B. R. Drug-induced steatohepatitis. Expert
opinion on drug metabolism & toxicology 2017, 13, 193-204.
18. Khan, A. Z.; Morris-Stiff, G.; Makuuchi, M. Patterns of chemotherapy-induced hepatic
injury and their implications for patients undergoing liver resection for colorectal liver
metastases. J. Hepatobiliary. Pancreat. 2009, 16, 137-144.
19. Maor, Y.; Malnick, S. Liver injury induced by anticancer chemotherapy and radiation
therapy. International journal of hepatology 2013, 2013.
20. Raptis, D. A.; Fischer, M. A.; Graf, R.; Nanz, D.; Weber, A.; Moritz, W.; Tian, Y.;
Oberkofler, C. E.; Clavien, P. MRI: the new reference standard in quantifying hepatic
steatosis? Gut 2012, 61, 117-127.
21. Anstee, Q. M.; Day, C. P. Epidemiology, Natural History, and Evaluation of Nonalcoholic
Fatty Liver Disease. In Zakim and Boyer's HepatologyElsevier: 2018; pp 391-405. e3.
22. Zezos, P.; Renner, E. L. Liver transplantation and non-alcoholic fatty liver disease. World
journal of gastroenterology: WJG 2014, 20, 15532.
23. Tolman, K. G.; Dalpiaz, A. S. Treatment of non-alcoholic fatty liver disease. Therapeutics
and clinical risk management 2007, 3, 1153.
24. Petersen, K. F.; Dufour, S.; Befroy, D.; Lehrke, M.; Hendler, R. E.; Shulman, G. I. Reversal
of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate
weight reduction in patients with type 2 diabetes. Diabetes 2005, 54, 603-608.
56

25. Suzuki, A.; Lindor, K.; St Saver, J.; Lymp, J.; Mendes, F.; Muto, A.; Okada, T.; Angulo, P.
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J.
Hepatol. 2005, 43, 1060-1066.
26. Huang, M. A.; Greenson, J. K.; Chao, C.; Anderson, L.; Peterman, D.; Jacobson, J.; Emick,
D.; Lok, A. S.; Conjeevaram, H. S. One-year intense nutritional counseling results in
histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am. J.
Gastroenterol. 2005, 100, 1072-1081.
27. Angulo, P. NAFLD, obesity, and bariatric surgery. Gastroenterology 2006, 130, 1848-1852.
28. Mattar, S. G.; Velcu, L. M.; Rabinovitz, M.; Demetris, A. J.; Krasinskas, A. M.; BarinasMitchell, E.; Eid, G. M.; Ramanathan, R.; Taylor, D. S.; Schauer, P. R. Surgically-induced
weight loss significantly improves nonalcoholic fatty liver disease and the metabolic
syndrome. Ann. Surg. 2005, 242, 610.
29. Clark, J. M.; Alkhuraishi, A. R.; Solga, S. F.; Alli, P.; Diehl, A. M.; Magnuson, T. H. Roux‐
en‐Y gastric bypass improves liver histology in patients with non‐alcoholic fatty liver
disease. Obes. Res. 2005, 13, 1180-1186.
30. Dixon, J. B.; Bhathal, P. S.; Hughes, N. R.; O'Brien, P. E. Nonalcoholic fatty liver disease:
improvement in liver histological analysis with weight loss. Hepatology 2004, 39, 16471654.
31. Sabuncu, T.; Nazligul, Y.; Karaoglanoglu, M.; Ucar, E.; Kilic, F. B. The effects of
sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver
enzyme levels in obese patients with non-alcoholic steatohepatitis. Romanian journal of
gastroenterology 2003, 12, 189-192.
32. Zelber-Sagi, S.; Kessler, A.; Brazowsky, E.; Webb, M.; Lurie, Y.; Santo, M.; Leshno, M.;
Blendis, L. M.; Halpern, Z.; Oren, R. In In Randomized placebo-controlled trial of orlistat
for the treatment of patients with non alcoholic fatty liver disease (NAFLD); Hepatology;
JOHN WILEY & SONS INC 111 RIVER ST, HOBOKEN, NJ 07030 USA: 2004; Vol. 40,
pp 237A.
33. Castera, L.; Vilgrain, V.; Angulo, P. Noninvasive evaluation of NAFLD. Nature reviews
Gastroenterology & hepatology 2013, 10, 666-675.
34. Stern, C.; Castera, L. Non-invasive diagnosis of hepatic steatosis. Hepatology international
2017, 11, 70-78.
35. Bydder, G. M.; Kreel, L.; Chapman, R. W.; Harry, D.; Sherlock, S.; Bassan, L. Accuracy of
computed tomography in diagnosis of fatty liver. Br. Med. J. 1980, 281, 1042.

57

36. Piekarski, J.; Goldberg, H. I.; Royal, S. A.; Axel, L.; Moss, A. A. Difference between liver
and spleen CT numbers in the normal adult: its usefulness in predicting the presence of
diffuse liver disease. Radiology 1980, 137, 727-729.
37. Mehta, S. R.; Thomas, E. L.; Bell, J. D.; Johnston, D. G.; Taylor-Robinson, S. D. Noninvasive means of measuring hepatic fat content. World journal of gastroenterology: WJG
2008, 14, 3476.
38. Park, S. H.; Kim, P. N.; Kim, K. W.; Lee, S. W.; Yoon, S. E.; Park, S. W.; Ha, H. K.; Lee,
M.; Hwang, S.; Lee, S. Macrovesicular hepatic steatosis in living liver donors: use of CT for
quantitative and qualitative assessment. Radiology 2006, 239, 105-112.
39. Idilman, I. S.; Keskin, O.; Celik, A.; Savas, B.; Halil Elhan, A.; Idilman, R.; Karcaaltincaba,
M. A comparison of liver fat content as determined by magnetic resonance imaging-proton
density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta
Radiol. 2016, 57, 271-278.
40. Reeder, S. B.; Cruite, I.; Hamilton, G.; Sirlin, C. B. Quantitative assessment of liver fat with
magnetic resonance imaging and spectroscopy. Journal of magnetic resonance imaging
2011, 34, 729-749.
41. Permutt, Z.; Le, T.; Peterson, M. R.; Seki, E.; Brenner, D. A.; Sirlin, C.; Loomba, R.
Correlation between liver histology and novel magnetic resonance imaging in adult patients
with non‐alcoholic fatty liver disease–MRI accurately quantifies hepatic steatosis in
NAFLD. Aliment. Pharmacol. Ther. 2012, 36, 22-29.
42. Hines, C. D.; Frydrychowicz, A.; Hamilton, G.; Tudorascu, D. L.; Vigen, K. K.; Yu, H.;
McKenzie, C. A.; Sirlin, C. B.; Brittain, J. H.; Reeder, S. B. T1 independent, T2* corrected
chemical shift based fat–water separation with multi‐peak fat spectral modeling is an
accurate and precise measure of hepatic steatosis. Journal of magnetic resonance imaging
2011, 33, 873-881.
43. Siegelman, E. S.; Rosen, M. A. In In Imaging of hepatic steatosis; Seminars in Liver
Disease; Copyright© 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New
…: 2001; Vol. 21, pp 71.
44. Dixon, W. T. Simple proton spectroscopic imaging. Radiology 1984, 153, 189-194.
45. Lee, J. K.; Dixon, W. T.; Ling, D.; Levitt, R. G.; Murphy Jr, W. A. Fatty infiltration of the
liver: demonstration by proton spectroscopic imaging. Preliminary observations. Radiology
1984, 153, 195-201.
46. Heiken, J. P.; Lee, J. K.; Dixon, W. T. Fatty infiltration of the liver: evaluation by proton
spectroscopic imaging. Radiology 1985, 157, 707-710.

58

47. Reeder, S. B.; Sirlin, C. B. Quantification of liver fat with magnetic resonance imaging.
Magnetic Resonance Imaging Clinics 2010, 18, 337-357.
48. Bannas, P.; Kramer, H.; Hernando, D.; Agni, R.; Cunningham, A. M.; Mandal, R.; Motosugi,
U.; Sharma, S. D.; Munoz del Rio, A.; Fernandez, L. Quantitative magnetic resonance
imaging of hepatic steatosis: Validation in ex vivo human livers. Hepatology 2015, 62,
1444-1455.
49. Yu, H.; McKenzie, C. A.; Shimakawa, A.; Vu, A. T.; Brau, A. C.; Beatty, P. J.; Pineda, A.
R.; Brittain, J. H.; Reeder, S. B. Multiecho reconstruction for simultaneous water‐fat
decomposition and T2* estimation. Journal of Magnetic Resonance Imaging: An Official
Journal of the International Society for Magnetic Resonance in Medicine 2007, 26, 11531161.
50. Chebrolu, V. V.; Hines, C. D.; Yu, H.; Pineda, A. R.; Shimakawa, A.; McKenzie, C. A.;
Samsonov, A.; Brittain, J. H.; Reeder, S. B. Independent estimation of T* 2 for water and fat
for improved accuracy of fat quantification. Magnetic Resonance in Medicine: An Official
Journal of the International Society for Magnetic Resonance in Medicine 2010, 63, 849857.
51. Hernando, D.; Liang, Z.; Kellman, P. Chemical shift-based water/fat separation: A
comparison of signal models. Magnetic resonance in medicine 2010, 64, 811-822.
52. Horng, D. E.; Hernando, D.; Hines, C. D.; Reeder, S. B. Comparison of R2* correction
methods for accurate fat quantification in fatty liver. Journal of Magnetic Resonance
Imaging 2013, 37, 414-422.
53. Zaitoun, A. M.; Al Mardini, H.; Awad, S.; Ukabam, S.; Makadisi, S.; Record, C. O.
Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic
hepatitis C. J. Clin. Pathol. 2001, 54, 461-465.
54. Boyles, T. H.; Johnson, S.; Garrahan, N.; Freedman, A. R.; Williams, G. T. A validated
method for quantifying macrovesicular hepatic steatosis in chronic hepatitis C. Analytical
and quantitative cytology and histology 2007, 29, 244-250.
55. Sethunath, D.; Morusu, S.; Tuceryan, M.; Cummings, O. W.; Zhang, H.; Yin, X.;
Vanderbeck, S.; Chalasani, N.; Gawrieh, S. Automated assessment of steatosis in murine
fatty liver. PloS one 2018, 13.
56. Vanderbeck, S.; Bockhorst, J.; Komorowski, R.; Kleiner, D. E.; Gawrieh, S. Automatic
classification of white regions in liver biopsies by supervised machine learning. Hum.
Pathol. 2014, 45, 785-792.
57. Nativ, N. I.; Chen, A. I.; Yarmush, G.; Henry, S. D.; Lefkowitch, J. H.; Klein, K. M.;
Maguire, T. J.; Schloss, R.; Guarrera, J. V.; Berthiaume, F. Automated image analysis

59

method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosinstained histology images of human livers. Liver Transplantation 2014, 20, 228-236.
58. Marsman, H.; Matsushita, T.; Dierkhising, R.; Kremers, W.; Rosen, C.; Burgart, L.; Nyberg,
S. L. Assessment of donor liver steatosis: pathologist or automated software? Hum. Pathol.
2004, 35, 430-435.
59. Roullier, V.; Cavaro-Menard, C.; Guillaume, C.; Aube, C. In In Fuzzy algorithms to extract
vacuoles of steatosis on liver histological color images; 2007 29th Annual International
Conference of the IEEE Engineering in Medicine and Biology Society; IEEE: 2007; , pp
5575-5578.
60. Liquori, G. E.; Calamita, G.; Cascella, D.; Mastrodonato, M.; Portincasa, P.; Ferri, D. An
innovative methodology for the automated morphometric and quantitative estimation of
liver steatosis. Histol. Histopathol. 2009.
61. Otsu, N. A threshold selection method from gray-level histograms. IEEE Trans. Syst. Man
Cybern. 1979, 9, 62-66.
62. Homeyer, A.; Schenk, A.; Arlt, J.; Dahmen, U.; Dirsch, O.; Hahn, H. K. Fast and accurate
identification of fat droplets in histological images. Comput. Methods Programs Biomed.
2015, 121, 59-65.
63. Vanderbeck, S.; Bockhorst, J.; Kleiner, D.; Komorowski, R.; Chalasani, N.; Gawrieh, S.
Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic
fatty liver disease liver biopsies. Hum. Pathol. 2015, 46, 767-775.
64. Ghugre, N. R.; Wood, J. C. Relaxivity-iron calibration in hepatic iron overload: probing
underlying biophysical mechanisms using a Monte Carlo model. Magnetic resonance in
medicine 2011, 65, 837-847.
65. Yamada, I.; Aung, W.; Himeno, Y.; Nakagawa, T.; Shibuya, H. Diffusion coefficients in
abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echoplanar MR imaging. Radiology 1999, 210, 617-623.
66. Hamilton, G.; Yokoo, T.; Bydder, M.; Cruite, I.; Schroeder, M. E.; Sirlin, C. B.; Middleton,
M. S. In vivo characterization of the liver fat 1H MR spectrum. NMR Biomed. 2011, 24,
784-790.
67. Tipirneni-Sajja, A.; Krafft, A. J.; Loeffler, R. B.; Song, R.; Bahrami, A.; Hankins, J. S.;
Hillenbrand, C. M. Autoregressive moving average modeling for hepatic iron quantification
in the presence of fat. Journal of Magnetic Resonance Imaging 2019, 50, 1620-1632.
68. Hernando, D.; Haufe, W. M.; Hooker, C. A.; Schlein, A.; Wolfson, T.; Artz, N. S.; Reeder, S.
B.; Sirlin, C. B. In In Relationship between liver proton density fat fraction and R2* in the
absence of iron overload; Proc ISMRM; 2015; Vol. 4118.
60

69. Leporq, B.; Lambert, S. A.; Ronot, M.; Vilgrain, V.; Van Beers, B. E. Simultaneous MR
quantification of hepatic fat content, fatty acid composition, transverse relaxation time and
magnetic susceptibility for the diagnosis of non‐alcoholic steatohepatitis. NMR Biomed.
2017, 30, e3766.
70. Hernando, D.; Vigen, K. K.; Shimakawa, A.; Reeder, S. B. R mapping in the presence of
macroscopic B0 field variations. Magnetic resonance in medicine 2012, 68, 830-840.
71. Valenti, L.; Rametta, R.; Dongiovanni, P.; Motta, B. M.; Canavesi, E.; Pelusi, S.; Pulixi, E.
A.; Fracanzani, A. L.; Fargion, S. The A736V TMPRSS6 polymorphism influences hepatic
iron overload in nonalcoholic fatty liver disease. PLoS One 2012, 7.
72. Changqing Wang, Benjamin Ratliff, Claude Sirlin, Scott Reeder DH Monte Carlo Modeling
of Liver MR Signal in the Presence of Fat. International Society for Magnetic Resonance in
Medicine. 2018, 26.
73. Hernando, D.; Liang, Z.; Kellman, P. Chemical shift–based water/fat separation: A
comparison of signal models. Magnetic resonance in medicine 2010, 64, 811-822.
74. Dulai, P. S.; Sirlin, C. B.; Loomba, R. MRI and MRE for non-invasive quantitative
assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical
practice. J. Hepatol. 2016, 65, 1006-1016.

61

